64
Participants
Start Date
April 23, 2019
Primary Completion Date
December 30, 2026
Study Completion Date
December 30, 2026
[18-F]- FDG - PET
\[F-18\]-FDG Injection is an intravenous diagnostic radiopharmaceutical used for Positron Emission Tomography. While this is not the subject of investigation in this study, \[F-18\]-FDG will be used in the PET imaging assessment of study participants during their 3 month follow-up post-treatment.
RECRUITING
University Health Network, The Princess Margaret, Toronto
Sunnybrook Health Sciences Centre
OTHER
University Health Network, Toronto
OTHER